Infusing Optimal TILs

Time: 2:35 pm
day: Day Two

Details:

  • Functional improvements of TIL through the use of agonistic 41BB stimulation
  • Genetic engineering of TGF-β dominant negative receptor in TIL for the treatment of metastatic melanoma

Speakers: